Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current problems in primary biliary cirrhosis

J Neuberger1

  • 1Liver Unit, Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Edgbaston, Brimingham, U.K.

Zeitschrift Fur Gastroenterologie
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect on consent rates for deceased organ donation in Wales after the introduction of an opt-out system.

Anaesthesia·2020
Same author

Editorial: covert hepatic encephalopathy-silent but serious.

Alimentary pharmacology & therapeutics·2018
Same author

Confirmation of specificity of reactivity in a solid phase ELISA for the detection of hepatitis E viral antigen improves utility of the assay.

Journal of virological methods·2017
Same author

Donors With Immune Thrombocytopenia: Do They Pose a Risk to Transplant Recipients?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis.

Alimentary pharmacology & therapeutics·2016
Same author

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same journal

[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

[Updated S3 guideline on ulcerative colitis].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
See all related articles

Primary biliary cholangitis (PBC) pathogenesis remains uncertain, with no effective therapies. Research suggests abnormal antigen expression on biliary cells may explain anti-mitochondrial antibody involvement, offering new insights into this enigmatic liver disease.

Area of Science:

  • Hepatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Primary biliary cholangitis (PBC) is an enigmatic liver disease with uncertain pathogenesis and limited effective therapies.
  • Current treatments offer only modest benefits, and proposed etiologies, including autoimmune and infectious causes, lack definitive evidence.
  • The strong association with anti-mitochondrial antibodies (AMAs) is a key feature, but their precise role in disease development is unclear.

Purpose of the Study:

  • To investigate the role of anti-mitochondrial antibodies in the pathogenesis of Primary Biliary Cholangitis.
  • To explore potential explanations for the observed association between AMAs and PBC.
  • To identify potential new therapeutic targets by understanding antigen expression in biliary epithelial cells.

Main Methods:

Related Experiment Videos

  • Review of existing literature on PBC etiology and treatment.
  • Analysis of the known antigens targeted by AMAs in PBC.
  • Investigation of biliary epithelial cell surface antigen expression.

Main Results:

  • Corticosteroid therapy shows limited efficacy in PBC compared to other autoimmune liver diseases.
  • No infectious agent has been reliably identified as the cause of PBC.
  • Identified ubiquitous mitochondrial enzymes as AMA targets, but their role in pathogenesis is uncertain.
  • Preliminary findings suggest some AMA antigens may be expressed on the surface of biliary epithelial cells.

Conclusions:

  • The pathogenesis of Primary Biliary Cholangitis remains largely unknown, highlighting the need for further research.
  • Abnormal expression of mitochondrial antigens on biliary epithelial cells may be a crucial factor in AMA-mediated damage in PBC.
  • Further studies are required to confirm these findings and elucidate the mechanisms behind abnormal antigen expression.